Syncytin 2 is a newly identified placental membrane protein with fusogenic and immunosuppressive activities. Major facilitator superfamily domain containing 2A (MFSD2A) is the cognate receptor for syncytin 2-mediated cell-cell fusion. Both syncytin 2 and MFSD2A are highly expressed in placenta. In this study to understand the regulation of syncytin 2 and MFSD2A expression in placenta, we found that syncytin 2 gene is epigenetically silenced in nonplacental cells by cytosinephosphate-guanine (CpG) dinucleotide methylation and that expression of syncytin 2 and MFSD2A genes are regulated by the placental transcription factor GCM1 in placental cells. Functional GCM1-binding sites were identified in syncytin 2 and MFSD2A promoters based on electrophoretic mobility shift assay and chromatin immunoprecipitation assay. Because GCM1 activity is decreased in hypoxic placental cells, we further confirmed that expression of MFSD2A is downregulated in hypoxic BeWo choriocarcinoma cells. Interestingly, ectopic expression of GCM1 activated syncytin 2 and MFSD2A expression in MCF-7 breast cancer cells and facilitated MCF-7 cell fusion. The expression of syncytin 2 in MCF-7 cells was partly attributed to CpG demethylation in the syncytin 2 promoter in the presence of GCM1. Our results suggest that GCM1 is a critical factor in controlling placental cell fusion through transcriptional regulation of syncytin 2 and MFSD2A gene expression in placenta. In addition, GCM1 may also play an important role in the epigenetic regulation of syncytin 2 gene expression.
INTRODUCTION
Syncytiotrophoblast is a multinucleated cell layer on the outer surface of human placental villi. The physiological functions of syncytiotrophoblast include gas and nutrient exchange between fetus and mother, hormone production, and immunomodulation. Formation of syncytiotrophoblast depends upon cell-cell fusion of subjacent mononucleated cytotrophoblasts. ERVWE1 (syncytin 1), endogenous retrovirus family W, env(C7), member 1 was the first identified functional fusogenic protein involved in mediation of placental cell fusion [1, 2] . Specifically, antiserum targeting ERVWE1 and antisense oligonucleotides were able to block cell-cell fusion of BeWo cells [1, 3] . In addition, ectopic expression of ERVWE1 in nonplacental cells, such as HeLa and 293T cells, induced cell fusion. ERVWE1 shares sequence homology with a large interference group of retroviruses that use SLC1A5, solute carrier family 2 (neutral amino acid transporter), member 5 (previously known as human sodium-dependent neutral amino acid transporter type 2 [ASCT2 or RDR]) as their common receptor [4] . Further characterization demonstrated that both SLC1A5 and a related transporter, SLC1A4, are the functional receptors for ERVWE1 [5] .
Recent in silico analysis of human genome databases has revealed a second placental fusogenic protein named syncytin 2, which is an envelope protein of the HERV family FRD [6] . Interestingly, unlike ERVWE1, syncytin 2 possesses potential immunosuppressive activity. This has been evidenced by overexpression of syncytin 2 in tumor cells, preventing their rejection in allogenic mouse hosts [7] . Both ERVWE1 and syncytin 2 genes encode a polypeptide of 538 amino acids, which is predicted to be posttranslationally cleaved into surface and transmemebrane subunits. However, functional characterization indicates that the surface and transmembrance subunits of ERVWE1 and syncytin 2 are not functionally exchangeable and that the cytoplasmic domain of ERVWE1 regulates its fusogenic activity [8, 9] . In addition, the receptor for syncytin 2 has been mapped to chromosome 1p34.2 by using a panel of human/hamster hybrid cell lines, harboring different human chromosomal fragments, to assay susceptibility to syncytin 2 pseudotypes. Further characterization identified major facilitator superfamily domain containing 2A (MFSD2A) as the receptor for syncytin 2 [10] . In terms of sequence and structural similarities, MFSD2A is similar to genes for bacterial permeases and symporter proteins, which belong to a protein superfamily of 10-12 transmembrane domains. Although the transporter function of human MFSD2A has not yet defined, the murine homologue is highly induced in brown adipose tissue during adaptive thermogenesis [11] . Interestingly, whereas ERVWE1 receptors (SLC1A4 and SLC1A5) are ubiquitously expressed in different tissues [12, 13] , MFSD2A is highly expressed in human placenta [10] . In addition, in situ hybridization demonstrates that MFSD2A is expressed in the syncytiotrophoblast layer [10] .
Clinically, expression of ERVWE1 and syncytin 2 is decreased during preeclampsia, a pregnancy disorder [9, 14] . It is highly possible that syncytin 2 plays important roles in both trophoblastic fusion and immunomodulation during placental development and that its aberrant expression may contribute to the development of preeclampsia. Because both syncytin 2 and MFSD2A are highly expressed in the placenta, it is important to understand how this is achieved at the molecular level. Here, we report that expression of syncytin 2 in the placenta is regulated at the epigenetic and transcriptional levels. We demonstrate that cytosine-phosphate-guanine (CpG) dinucleotides in the syncytin 2 promoter are hypermethylated in nonplacental cells. Moreover, the placental transcription factor GCM1 not only regulates the promoter activity of syncytin 2 in BeWo choriocarcinoma and MCF-7 breast cancer cells but also facilitates DNA demethylation of the syncytin 2 promoter in MCF-7 cells. In addition, GCM1 is able to upregulate MFSD2A promoter activity and gene expression in BeWo and MCF-7 cells. As a result, fusion of MCF-7 cells is stimulated by ectopic expression of GCM1. Results of the present study suggest that GCM1 is a critical transcription factor for syncytin 2 and MFSD2A expression in placenta. The potential mechanism underlying GCM1-associated DNA demethylation in the syncytin 2 promoter is discussed.
MATERIALS AND METHODS

Bisulfite Sequencing
Genomic DNA was extracted from term placental tissues and the indicated cultured cells. Tissues from three term placentas at 38-39 wk of gestation were obtained after delivery at Mackay Memorial Hospital (Taipei, Taiwan) with approval by the Ethics Committee [16] . Two micrograms of genomic DNA were subject to BamHI (NEB) digestion, followed by bisulfite conversion using a commercial reaction kit (Zymo Research). The syncytin 2 promoter region was amplified by nested PCR using the primer set 5 0 -GGTTAAGGATAGTA GATTATTTGAGG-3 0 and 5 0 -AATAAACTATCTACTATACAATAACC-3 0 for the first round and the primer set 5 0 -TTAGGAGGTTATTAGGT TAAGTTGG-3 0 and 5 0 -AATAAACTATCTACTATACAATAACC-3 0 for the second round. The amplified products were cloned into pGEM-T vector (Promega). At least nine transformed bacterial colonies were picked up and subjected to DNA sequencing.
Cell Culture
MCF-7 cells were maintained at 378C in alpha-minimum essential medium plus 10% fetal bovine serum (FBS). JEG-3, BeWo, and BeWo31 cells were maintained in Ham F12K medium plus 15% FBS. BeWo31 cells stably expressing HA-tagged GCM1 (HA-GCM1) have been described previously [15] . 293T cells were maintained in Dulbecco modified Eagle medium plus 10% FBS. In addition, 100 mg/ml of streptomycin and 100 U/ml of penicillin were included in all of the above-described media. Isolation and purification of villous cytotrophoblast cells from three term placentas at 38-39 wk of gestation were performed as described by Kliman et al. [17] . Purified cytotrophoblast cells were maintained at 378C in Iscove modified Dulbecco medium containing 10% FBS and the aforementioned antibiotics. To inhibit DNA methylation, cells were treated with 10 lM 5 0 -azacytidine and 300 nM trichostatin A for the indicated period of time. Hypoxia was achieved by exposing cells to 1% O 2 , 5% CO 2 , and 94% N 2 in a multigas incubator (Astec), whereas normoxia was achieved with 21% O 2 , 5% CO 2 , and balanced N 2 .
Plasmid Constructs and Transient and Adenoviral Expression
Genomic fragments covering different syncytin 2 and MFSD2A promoter regions were PCR amplified and cloned into the pGL3-Basic vector (Promega) for promoter analysis. pHA-GCM1 expression plasmid harbors the GCM1 open reading frame with an N-terminal triple HA tag under control of the EEF1A promoter. Ad-lox and ad-GCM1 adenoviruses, which harbor empty and HAtagged GCM1 expression cassettes, respectively, have been described previously [18] . For transient expression, cells were transfected with the indicated expression and reporter plasmids using Lipofectamine 2000 reagent (Invitrogen) according to the manufacturer's instructions and incubated for an additional 48 h. For adenoviral expression, cells in culture plates were first transfected with the indicated reporter plasmid and then infected with ad-GCM1 or ad-lox adenovirus at a multiplicity of infection of 10 at 378C for 90 min. After that, the virus was removed, fresh culture media added, and incubation continued for an additional 48 h. Cells were harvested in reporter lysis buffer (Promega), and luciferase activities were measured with a luciferase assay system (Promega). Reaction was initiated by adding luciferin, and light emission was monitored by a luminescence counter (PerkinElmer). Specific luciferase activities were normalized by protein concentration, which was measured using a BCA protein assay kit (Pierce).
In Vitro DNA Methylation
The genomic DNA of syncytin 2 promoter was methylated in vitro by incubating the DNA with SssI methylase (NEB) according to the manufacturer's instructions. Complete methylation of the DNA was verified by digestion with the methyl-sensitive restriction enzyme HpaII. To study the effect of methylation on syncytin 2 promoter, methylated and unmethylated genomic DNA was ligated with linearized pGL3-Basic and subsequently transfected into the indicated cell line for luciferase assays.
RNA Purification and Real-Time PCR
RNA was isolated from cultured cells using the RNeasy purification system (Qiagen). Total RNA content was evaluated by A 260 (optical density) measurement and its integrity checked by 1% agarose gel electrophoresis. First-strand complementary DNA was prepared using the SuperScript III firststrand synthesis system (Invitrogen). Real-time PCR was performed in a LightCycler machine (Roche) with a commercial SYBR Green reaction reagent (Qiagen). The primer sequences for gene amplification were as follows: syncytin 2, 
Electrophoretic Mobility Shift Assay
Electrophoretic mobility shift assay (EMSA) for the binding of GCM1 to syncytin 2 and MFSD2A promoters was performed as previously described [18] . In brief, recombinant maltose binding protein (MBP) and MBP-GCM1(1-167), which is an MBP fusion protein containing the DNA-binding domain of GCM1, were prepared and expressed in BL21(DE3) using the pMAL-c2 vector (NEB). Two oligonucleotides, SYN2GBS (5 0 -AGGCGACCATCAGGTGAT-3 0 ) and MFSD2AGBS (5 0 -GCGCAGGCAGATGCCGGTTCCGGGG-3 0 ), derived from the GCM1-binding sites (GBSs) in syncytin 2 and MFSD2A promoters were synthesized. End-labeled oligonucleotide probes were incubated with 20 ng of MBP or MBP-GCM1(1-167) proteins in a binding reaction buffer containing 50 mM Tris-HCl (pH 8.0), 100 mM NaCl, 2 mM MgCl 2 , 0.05 mM ZnCl 2 , 4 mM spermidine, 0.05% Nonidet P-40, 5 mM dithiothreitol, 10% glycerol, 0.25 lg of poly(dIdC), and 7.5 lg of bovine serum albumin. After incubation, the reaction mixtures were analyzed by electrophoresis on 5% nondenaturing polyacrylamide gels in running buffer (25 mM TrisHCl [pH 8.5], 190 mM glycine, and 1 mM ethylenediaminetetra-acetic acid) at 48C.
Chromatin Immunoprecipitation Assay
BeWo31 cells were subjected to chromatin immunoprecipitation (ChIP) assays as described previously [15] . The complexes of HA-GCM1 and genomic DNA fragments were immunoprecipitated by a monoclonal anti-HA antibody (Sigma). Specific sequences of syncytin 2 and MFSD2A promoter regions in the immunoprecipitates were detected by PCR with specific primers. PCR products were analyzed on 2% MetaPhor agarose gels (FMC). Sequences of primers were 5 0 -CCATTAGGTTAAGCTGGTTCTGTTA-3 0 and 5 0 -GGCTGCAA CCCAT TATTATT ATTTT-3 0 for syncytin 2, 5 0 -GCCTCGGTTTCCTCGCGCGTG-3 0 and 5 0 -AGCCCTCTCGGTTGCGGC CAA-3 0 for MFSD2A, and 5 0 -AAAAGCGGGGAGAAAGTAGG-3 0 and 5 0 -CTAGCCTCCCGGGTTTCTCT-3 0 for GAPDH.
Cell Fusion Assay
To monitor the effect of ectopic expression of GCM1 on MCF-7 cell fusion, enhanced green fluorescent protein (EGFP)-expressing MCF-7 cells were first established by a lentiviral expression system (SBI) to serve as the reporter cells in the cell fusion assay. The EGFP-expressing MCF-7 cells were infected with ad-lox or ad-GCM1. At 48 h postinfection, fusion events were examined under an Olympus microscope equipped with a cooled charge-coupled device camera (DP50; Olympus). Five microscopic fields per sample were randomly selected for examination in each of three independent experiments. Images were prepared for presentation using Adobe Photoshop 6.0. The stimulatory effect of GCM1 on MCF-7 cell fusion was calculated as a fusion index of (N À S)/T,
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where N is the number of nuclei in the syncytia, S is the number of syncytia, and T is the total number of nuclei counted, to measure the number of fusion events.
Statistics
The Student t-test was used to determine statistical significance for differences between means. A P value of less than 0.05 was considered to be significant.
RESULTS
Analysis of CpG Methylation in Syncytin 2 Promoter
Because epigenetic methylation has been reported to regulate HERV expression in placenta [19] , we investigated CpG methylation in the 5 0 -long terminal repeat (LTR) of syncytin 2 promoter. As shown in Figure 1A , CpG methylation in the 5 0 -LTR of syncytin 2 promoter was highly detected in human embryonic kidney 293T cells but barely detected in human BeWo choriocarcinoma cells, purified human cytotrophoblast cells, and human placental tissues. Because syncytin 2 promoter is methylated and not expressed in nonplacental cells, we studied whether CpG methylation regulates syncytin 2 promoter activity. The 5 0 -LTR fragment of syncytin 2 promoter was subject to in vitro methylation with SssI methylase. Complete methylation of the fragment was confirmed by its sensitivity to MspI and resistance to HpaII digestion (Fig. 1B,  top) . The methylated fragments were further ligated to the linearized promoterless pGL3-Basic reporter plasmid and transfected into BeWo and JEG-3 choriocarcinoma cells, 293T kidney cells, and MCF-7 breast cancer cells. Interestingly, the luciferase activity directed by the methylated 5 0 -LTR was significantly decreased in 293T and MCF-7 cells but not in JEG-3 and BeWo cells (Fig. 1B) . These results suggest that CpG methylation in the 5 0 -LTR of syncytin 2 significantly suppresses its activity in nonplacental cells but not in placental cells.
GCM1 Regulates Syncytin 2 Gene Expression
Our previous study demonstrated that GCM1 controls trophoblastic fusion via transcriptional regulation of the ERVWE1 gene [18] . However, this does not rule out the possibility that GCM1 may control trophoblastic fusion via regulation of additional fusogenic protein expression. Because syncytin 2 is also primarily expressed in placenta, we investigated whether GCM1 also regulates syncytin 2 expression in placenta. To this end, ectopic expression of GCM1 was introduced into BeWo and MCF-7 cells by infection with recombinant adenovirus, ad-GCM1, which harbors an HAtagged GCM1 expression cassette. For comparison, cells were also infected with a control adenovirus, ad-lox, which harbors an empty expression cassette.
By quantitative real-time PCR analysis, expression of syncytin 2 transcript was readily detected in BeWo cells but was barely detected in MCF-7 cells (data not shown). When exogenous HA-GCM1 was expressed in BeWo cells, elevated levels of syncytin 2 transcripts were detected compared with the ad-lox-infected cells, supporting the idea that GCM1 positively regulates syncytin 2 gene expression in placental cells ( Fig. 2A) . Interestingly, expression of HA-GCM1 also significantly increased the syncytin 2 transcript level in MCF-7 cells (Fig. 2B) . Although the level of syncytin 2 transcript stimulated by HA-GCM1 in MCF-7 cells was comparable to the endogenous level of syncytin 2 transcript in BeWo cells infected with ad-lox, the fold-induction of syncytin 2 expression by HA-GCM1 was much higher in MCF-7 than in BeWo cells (Fig. 2, compare A and B) . This discrepancy was very likely caused by residual expression of syncytin 2 transcript by endogenous GCM1 in BeWo cells, resulting in the stimulatory effect of exogenous HA-GCM1 on syncytin 2 expression being modest in BeWo cells. Taken together, these results suggest that GCM1 regulates syncytin 2 gene expression in placental and nonplacental cells.
GCM1 Facilitates CpG Demethylation of Syncytin 2 Promoter and Transactivates Syncytin 2 Promoter Activity
That the 5 0 -LTR in syncytin 2 promoter is methylated in nonplacental cells and that in vitro methylated 5 0 -LTR fragment suppresses reporter gene expression in nonplacental cells seem to contradict the observation that ectopic expression of GCM1 stimulates syncytin 2 expression in MCF-7 cells. To reconcile this contradiction, we tested whether GCM1 affects CpG methylation in the 5 0 -LTR of syncytin 2 in MCF-7 cells. Ad-lox-and ad-GCM1-infected MCF-7 cells were subject to methylation analysis of the 5 0 -LTR of syncytin 2. Interestingly, CpG methylation significantly decreased in the ad-GCM1-infected MCF-7 cells compared to the ad-lox-infected MCF-7 cells (Fig. 2C) . In a parallel study, CpG methylation in the ERVWE1 5 0 -LTR was not significantly affected in the ad-GCM1-infected MCF-7 cells (data not shown). We speculated that the CpGs in the 5 0 -LTRs of ERVWE1 and syncytin 2 promoters may exhibit differential susceptibility to epigenetic modification. Indeed, inhibition of DNA methylation in MCF-7 cells by 5 0 -azacytidine and trichostatin A decreased CpG methylation in the syncytin 2 5 0 -LTR (Fig. 2D) but not in the ERVWE1 5 0 -LTR (data not shown). Taken together, these results suggest that the CpGs in the 5 0 -LTR of syncytin 2 promoter are susceptible to demethylation and that exogenous GCM1 facilitates demethylation of these CpGs in MCF-7 cells.
Next, using transient expression experiments, we investigated whether GCM1 stimulates syncytin 2 promoter activity. Luciferase reporter constructs encompassing only the 5 0 -LTR of syncytin 2 or the 5 0 -LTR plus its 1-or 1.5-kb upstream region (Fig. 3A, top) were transfected into MCF-7 cells, followed by infection with ad-lox or ad-GCM1 adenovirus. As shown in the bottom of Figure 3A , HA-GCM1 was able to positively stimulate the reporter activity directed by 5 0 -LTR, 5 0 -LTR plus 1.5 kb, and 5 0 -LTR plus 1 kb promoter fragments. Because the 5 0 -LTR construct contains the minimal promoter region responsive to GCM1, we checked the sequence 5 0 -LTR and identified a potential GBS (5 0 -ACCATCAG-3 0 ). Indeed, deletion of this potential GBS (SYN2GBS) significantly diminished the responsiveness of syncytin 2 5 0 -LTR to HA-GCM1, suggesting that SYN2GBS is a responsive element to GCM1 (Fig. 3C) . Note the possibility of cryptic GCM1-responsive sites in syncytin 2 5 0 -LTR cannot be ruled out, because the SYN2GBS-deleted 5 0 -LTR fragment is still partially responsive to GCM1. We further confirmed by EMSA that GCM1 interacts with SYN2GBS. As shown in Figure 4A , recombinant MBP-GCM1 fusion protein, MBP-GCM1(1-167), which contains the DNA-binding domain of GCM1, specifically interacted with the SYN2GBS oligonucleotide probe. In addition, we also confirmed that GCM1 associates with the 5 0 -LTR of syncytin 2 by ChIP analysis in the BeWo31 cell line, which is a BeWo stable line expressing HA-GCM1. As shown in Figure 4B , the immunoprecipitated complex of HA monoclonal antibody, but not normal immunoglobulin G, contained syncytin 2 5 0 -LTR fragments 
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after PCR amplification, suggesting a specific association between HA-GCM1 and syncytin 2 promoter. Taken together, these results indicate that GCM1 is able to transactivate syncytin 2 expression via SYN2GBS in its promoter.
GCM1 Regulates MFSD2A Gene Expression
A recent study by Esnault et al. [10] has identified MFSD2A as the cognate receptor for syncytin 2. Because MFSD2A is highly expressed in placenta, we tested whether GCM1 is involved in MFSD2A gene expression in placenta. We performed quantitative real-time PCR assays to measure the levels of MFSD2A transcript in ad-lox-and ad-GCM1-infected BeWo and MCF-7 cells. As shown in Figure 2 , A and B, expression of HA-GCM1 in both cell lines stimulated MFSD2A gene expression. We further tested whether GCM1 stimulates MFSD2A promoter activity by transfection of different reporter constructs covering different regions of MFSD2A promoter into MCF7 cells, followed by infection with ad-lox or ad-GCM1 adenovirus (Fig. 3B, top) . As shown in Figure 3B , HA-GCM1 was able to positively stimulate reporter activity directed by 2-, 1-, 0.5-, and 0.3-kb promoter fragments of the MFSD2A gene. Similar results were observed in 293T cells transfected with the same set of reporter plasmids plus a GCM1 expression plasmid (data not shown). We also tested the function of a potential GBS (MFSD2AGBS) in the 0.3-kb promoter fragment by reporter assays. As shown in Figure 3C , deletion of MFSD2AGSB significantly decreased the responsiveness of the 0.3-kb promoter fragment to HA-GCM1. Therefore, at least a functional GBS was identified in the proximal promoter region of MFSD2A.
FIG. 3. GCM1
regulates the promoter activity of syncytin 2 and MFSD2A genes. A) GCM1 stimulates luciferase reporter expression directed by syncytin 2 promoter. A schematic representation of syncytin 2 reporter constructs is shown (top). MCF-7 cells were transfected with 0.2 lg of the indicated reporter plasmid, followed by infection with ad-lox or ad-GCM1 adenovirus. At 48 h postinfection, cells were harvested for luciferase activity. Values are presented as the mean and SD obtained from three independent experiments (**P , 0.01, *P , 0.05). B) GCM1 stimulates luciferase reporter expression directed by MFSD2A promoter. A schematic representation of MFSD2A reporter constructs is shown (top). Regulation of MFSD2A promoter activity by GCM1 was examined in MCF-7 cells using the indicated MFSD2A reporter plasmids and ad-lox and ad-GCM1 adenoviruses in a manner similar to A. Values are presented as the mean and SD obtained from three independent experiments (**P , 0.01, *P , 0.05). C) Functional characterization of functional GCM1-binding sites in syncytin 2 and MFSD2A promoters. SYN2GBS and MFSD2AGBS in the syncytin 2 5 0 -LTR and the MFSD2A 0.3-kb reporter plasmids, respectively, were deleted. The resulting reporter plasmids, 5 0 -LTRdGBS and 0.3 KbdGBS, were transfected into MCF-7 cells for their responsiveness to GCM1 as described in A. Values are presented as the mean and SD obtained from three independent experiments (**P , 0.01, *P , 0.05). D) Expression of MFSD2A is decreased by hypoxia. BeWo cells were incubated under normoxic and hypoxic conditions for 72 h and then harvested for quantitative realtime PCR analysis of the MFSD2A transcript level. The relative MFSD2A mRNA in hypoxic BeWo cells was normalized against the normoxic cells. Values are presented as the mean and SD obtained from three independent experiments (**P , 0.01).
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This conclusion is further supported by EMSA and ChIP analysis to demonstrate the interaction between GCM1 and MFSD2A promoter. As shown in Figure 4A , MBP-G C M 1 ( 1 -1 6 7 ) s p e c i f i c a l l y i n te r a c te d w i t h t h e MFSD2AGBS oligonucleotide probe. Furthermore, ChIP analysis performed in BeWo31 cells also demonstrated a specific association between HA-GCM1 and the MFSD2A promoter harboring the MFSD2AGBS element (Fig. 4B) . In addition, we have recently demonstrated that expression of GCM1 and its target genes ERVWE1 and syncytin 2 is decreased by hypoxia [9, 20] . This is most likely caused by disruption of the GCM1 transcriptional network via hypoxiaenhanced GCM1 degradation [21] . Because GCM1 regulates MFSD2A expression, we investigated whether MFSD2A expression is affected in BeWo cells under hypoxia. As shown in Figure 3D , the transcript level of MFSD2A was significantly decreased in BeWo cells under hypoxic conditions for 72 h. Therefore, the observed suppression of MFSD2A gene expression by hypoxia is very likely caused by decreased GCM1 activity.
Ectopic Expression of GCM1 Stimulates Cell-Cell Fusion in MCF-7 Cells
The observation that GCM1 upregulates syncytin 2 and MFSD2A gene expression in MCF-7 cells prompted us to investigate whether ectopic expression of GCM1 stimulates MCF-7 cell-cell fusion. To this end, MCF-7 cells were first transduced with a lentivirus harboring an EGFP expression cassette to establish reporter cells for fusion assay. The reporter MCF-7 cells expressing EGFP were then infected with ad-lox or ad-GCM1 adenoviruses. As shown in Figure 5A (right) , immunoblotting analysis demonstrated that HA-GCM1 was only expressed in the MCF-7 cells infected with ad-GCM1 adenovirus. Furthermore, microscopy revealed that syncytium formation was barely detected in the MCF-7 reporter cells infected with the ad-lox adenovirus but was significantly increased in the MCF-7 reporter cells infected with the ad-GCM1 adenovirus (Fig. 5A, left) . Quantitatively, ectopic expression of HA-GCM1 increases the efficiency of cell fusion in MCF-7 reporter cells by approximately threefold that of the control (Fig. 5B) . These results suggest that GCM1 is able to regulate cell-cell fusion via transcriptional activation of syncytin 2 and MFSD2A genes.
DISCUSSION
ERVWE1 and syncytin 2 are two critical fusogenic proteins in human placental cell fusion. Interestingly, syncytin 2 plays an additional role in immunosuppression, which may protect the fetus from the surveillance of the maternal immune system [7] . In another study [22] , two functional equivalents of human syncytin genes, called syncytin A and B by those authors, were identified from the endogenous retroviral sequences in the murine genome. Their official symbols are Gm52 (syncytin A) and D930020E02Rik (syncytin B) while a system for naming transcriptionally active endogenous retroviral sequences is developed. Mouse placenta contains two syncytiotrophoblast layers, SynT-I and SynT-II. SynT-I faces the maternal blood space, whereas SynT-II is in contact with fetal blood vessel. Interestingly, in situ hybridization demonstrated that syncytin A and B are expressed in SynT-I and SynT-II, respectively [23] . Although human syncytins and murine syncytins do not share significant sequence similarity, they are all capable of mediating cell-cell fusion and are specifically expressed in placental cells. Independent adaptation of ERV envelope proteins in different species during evolution suggests that these proteins play critical roles in placental development and function. Indeed, the results of a recent study supported the idea that syncytin-A is critical for formation of SynT-I layer, because gene targeting of syncytin A leads to overexpansion of unfused trophoblast cells, decreased fetal blood vessel spaces, and poor placental vascularization [24] . It is anticipated that syncytin B is essential for development of the SynT-II layer, although a gene-targeting study of syncytin B is still underway .   FIG. 4 . Association of GCM1 with syncytin 2 and MFSD2A promoters. A) Interaction of GCM1 and the identified GBSs in syncytin 2 and MFSD2A promoters. Recombinant MBP or MBP-GCM1(1-167) was incubated with SYN2GBS (left) or MFSD2AGBS (right) oligonucleotide probe in EMSAs. Comp, unlabeled SYN2GBS or MFSD2AGBS oligonucleotide in a 100-fold (1003) excess. B) Association of GCM1 with syncytin 2 and MFSD2A promoters. BeWo31 cells were analyzed by ChIP assays in the absence of antibody (no Ab), presence of normal mouse immunoglobulin G (IgG), or a mouse anti-HA monoclonal antibody. The immunopurified DNA fragments were PCR amplified for promoter regions covering SYN2GBS and MFSD2AGBS in the syncytin 2 and MFSD2A genes, respectively. As a control, a promoter region in the GAPDH gene was amplified.
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By analogy, it is very likely that ENVWE1 and syncytin 2 are also essential for proper placental development in humans.
Both syncytin 2 and its receptor MFSD2A are highly expressed in the placenta. In the present study, we demonstrated that expression of syncytin 2 gene is epigenetically regulated by CpG methylation such that the 5 0 -LTR of syncytin 2 promoter is hypomethylated in placental cells and hypermethylated in nonplacental cells. A similar finding that syncytin 2 promoter is hypomethylated in placenta has recently been reported by Gimenez et al. [25] . Importantly, we further demonstrated that expression of both syncytin 2 and MFSD2A genes are regulated by GCM1 at the transcriptional level in the placenta. In addition, GCM1 not only stimulates syncytin 2 and MFSD2A gene expression in placental but also in nonplacental cells. Ectopic expression of GCM1 in MCF-7 breast cancer cells results in CpG hypomethylation in the 5 0 -LTR of syncytin 2 promoter and promotes MCF-7 cell fusion. A possible mechanism underlying CpG hypomethylation in syncytin 2 promoter by GCM1 may involve active DNA demethylation. Because the SYN2GBS element is within the syncytin 2 5 0 -LTR promoter, it is feasible to speculate that GCM1 may recruit proteins with demethylation activity to promote CpG demethylation and then transactivate syncytin 2 expression.
Recent studies have indicated that nucleotide excision repair (NER) and base excision repair (BER) are involved in active DNA demethylation [26] . Growth arrest and DNA damageinducible 45 alpha (GADD45A) was identified to activate a methylated DNA reporter plasmid by activating NER machinery. In this scenario, GADD45A interacts with the NER endonuclease ERCC5 (previously XPG) to recognize and remove the 5 0 -methylcytosine-containing nucleotides, followed by DNA polymerases and ligase to fill the gap with unmethylated nucleotides [27] . On the other hand, thymine DNA glycosylase (TDG) of BER machinery was reported to mediate cytosine demethylation. It is believed that TDG cleaves the glycosidic bond to create an abasic site, which is then removed by endonucleases and filled by DNA polymerase and ligases. Recently, TDG has been shown to corroborate with DNMT3A/B, DDX5 (p68 RNA helicase), and other BER proteins to mediate CpG demethylation in the TFF1 (pS2) gene promoter [28, 29] . TDG also interacts with nuclear receptors, RAR and RXR, to enhance their transcriptional activation [30] . In addition to GADD45A and TDG, other factors, such as activation-induced cytidine deaminase (AICDA) and the DNA glycosylase MBD4, have also been reported to mediate active DNA demethylation [31, 32] . AICDA is required for active DNA demethylation and nuclear reprogramming toward pluripotency in human somatic cells, whereas MBD4 is involved in promoter demethylation of CYP27B1 induced by parathyroid hormone.
To explore the role of GCM1 in regulating hypomethylation of syncytin 2 promoter, we have tested the interaction between GCM1 and GADD45A or TDG. Interestingly, we detected interaction between GCM1 and TDG but not with GADD45A (unpublished results). It is possible that GCM1 may recruit TDG and other BER proteins to mediate site-specific CpG demethylation in the syncytin 2 promoter. Nevertheless, the possibility of AICDA and MBD4 working with GCM1 in regulation of CpG demethylation in syncytin 2 promoter cannot be ruled out. The underlying mechanism for GCM1 to regulate CpG demethylation of syncytin 2 promoter awaits further investigation.
The finding that GCM1 regulates active DNA demethylation in MCF-7 cells raises an interesting issue of whether exogenous GCM1 also mediates hypomethylation of ENVWE1 promoter in MCF-7 cells. In fact, ectopic expression of GCM1 failed to cause hypomethylation of ENVWE1 promoter and to upregulate ENVWE1 expression in MCF-7 cells. Because SYN2GBS is within and close to the CpGs in the 5 0 -LTR of syncytin 2 (Fig. 2C) , this may efficiently facilitate CpG demethylation by GCM1. To the contrary, the functional GBSs in ENVWE1 gene are upstream of and away from the CpGs in   FIG. 5 . GCM1 regulation of cell-cell fusion. A) Ectopic expression of GCM1 stimulates MCF-7 cell fusion. EGFP-expressing MCF-7 cells were infected with adlox or ad-GCM1 adenovirus for 48 h. Syncytium formation via cell-cell fusion was examined by microscopy at 3200 magnification. Note the formation of a multinucleated syncytium in the MCF-7 cells infected with the ad-GCM1 adenovirus. After microscopy examination, cells were harvested for immunoblotting analysis with anti-HA and anti-ACTB monoclonal antibodies to measure the protein levels of HA-GCM1 and ACTB (a loading control), respectively. B) Quantification of GCM1-induced cell-cell fusion by fusion index analysis of the experiments described in A. Values are presented as the mean and SD obtained from three independent experiments (**P , 0.01).
its 5 0 -LTR [17, 19] and may not, therefore, be sufficient for GCM1 to induce DNA demethylation in ENVWE1 promoter. Moreover, unlike syncytin 2, the CpGs in ENVWE1 5 0 -LTR in MCF-7 cells are resistant to chemical demethylation by 5 0 -azacytidine and trichostatin A. The finding that the CpGs in ENVWE1 5 0 -LTR are resistant to chemical demethylation has also been reported in HeLa cells [19] . Although the mechanism underlying the resistance of ENVWE1 promoter to DNA demethylation is unknown, this intrinsic property may also impede GCM1-induced DNA demethylation in ERVWE1 promoter.
The finding that GCM1 regulates syncytin 2 expression fits with our previous observation that expression of both GCM1 and syncytin 2 is decreased by hypoxia [9, 21] . We have recently demonstrated that GSK3B is activated in placental cells in hypoxia. The activated GSK3B is able to phosphorylate Ser322 in GCM1, which is recognized by FBXW2 for subsequent ubiquitination and degradation [21] . Therefore, decreased expression of syncytin 2 in hypoxia is very likely caused by impaired GCM1 activity.
That human MFSD2A is highly expressed in placenta suggests positive evolutionary selection in coordination of syncytin 2 functions in placenta. This argument is supported by several lines of evidence. First, murine MFSD2A is not susceptible to syncytin 2 pseudotype infection and is expressed in most tissues [10] . Therefore, murine MFSD2A may not function as a receptor for syncytin A or B. Second, human MFSD2A is a target gene of GCM1, and its expression can be specifically activated by GCM1 in placenta. Third, expression of MFSD2A in BeWo choriocarcinoma cells is stimulated by the cAMP-stimulant forskolin, which is known to stimulate placental cell fusion [10] . Our previous study has demonstrated that forskolin activates the cAMP-protein kinase A signaling pathway to facilitate CREB-binding protein-mediated GCM1 acetylation, which prevents GCM1 from ubiquitination and thereby elevates GCM1 activity [15] . In line with the ChIP experiment that demonstrates the association of GCM1 with the MFSD2A promoter, we speculated that stimulation of MFSD2A expression by forskolin is very likely caused by elevated GCM1 activity. In addition, decreased expression of MFSD2A by hypoxia can be attributed to enhanced GCM1 degradation. Overall, the present study has identified syncytin 2 and MFSD2A as two new GCM1 target genes involved in control of trophoblastic fusion, and abnormal expression of both genes may impair syncytiotrophoblast differentiation when GCM1 activity is dysregulated.
